Login
$ARI
$6.60 +$0.00 (0.0%) Live

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets:
Cash and cash equivalents
Commercial mortgage loans, net
Commercial Mortgage Portfolio Segment
Subordinate Mortgage Portfolio Segment
Total commercial mortgage loans, net
Real estate owned, held for investment, net
Real estate owned, held for investment, net (net of $43,048 and $34,438 accumulated depreciation in 2026 and 2025, respectively)
Other assets
Note receivable, held for sale
Commercial Mortgage Portfolio Segment
Total note receivable, held for sale
Derivative assets, net
Assets related to real estate owned, held for sale
Total Assets
Liabilities and Stockholders' Equity
Liabilities:
Secured debt arrangements, net
Secured Debt
Mortgages
Senior secured term loans and notes, net
Secured Debt
Senior Notes
Convertible senior notes, net
Debt related to real estate owned, held for investment, net
Mortgages
Total debt related to real estate owned, held for investment, net
Participations sold
Commercial Mortgage Portfolio Segment
Total participations sold
Accounts payable, accrued expenses and other liabilities
Derivative liabilities, net
Payable to related party
Related Party
Total Liabilities
Stockholders' Equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized, Series B-1, 6,770,393 shares issued and outstanding ($169,260 liquidation preference) in 2026 and 2025 (see Note 15)
Common stock, $0.01 par value, 450,000,000 shares authorized, 128,212,093 and 138,943,831 shares issued and outstanding in 2026 and 2025, respectively
Additional paid-in-capital
Accumulated deficit
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support